Abstract: A method of inhibiting carcinogen mediated conversion of melanocyte cells and protecting DNA against carcinogen-mediated damage by administering a composition comprising a water insoluble carotenoid such as beta-carotene is disclosed.
Type:
Grant
Filed:
January 16, 1997
Date of Patent:
August 6, 2002
Assignee:
Cognis Australia Pty., Ltd.
Inventors:
Lance Elliot Schlipalius, Julie A. Buckmeier, Frank L. Meyskens, Jr.